Brimonidine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Brimonidine
Buprenorphine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can slow down your brain and body a little. Brimonidine (found in eye drops like Alphagan or the skin cream Mirvaso) can make some people feel drowsy or tired, even though it is used in the eye or on the skin. Buprenorphine (like Belbuca or BuTrans) is a strong pain and opioid medicine that can also cause sleepiness and slower breathing.
Taken together, they could add up and make you feel more sleepy, dizzy, or foggy than usual. This is mostly a theoretical concern, so please don't worry. Keep taking both as prescribed, and let your pharmacist or doctor know how you feel so they can keep an eye on things.
Mechanism: Additive CNS depression. Brimonidine is a central alpha-2 agonist and, despite ophthalmic/topical routes, can produce systemic sedation; buprenorphine is a partial opioid agonist with sedative and respiratory-depressant potential. Neither is a prodrug relevant here; effect is pharmacodynamic, not metabolic.
- Direction: Additive sedation/CNS depression (increased combined effect).
- Severity/Evidence: Moderate; theoretical.
- Onset: Unspecified.
- Management: Assess for excess sedation, dizziness, and respiratory depression, particularly with systemic buprenorphine formulations. Counsel on additive drowsiness. Dose/route may be individualized and monitoring increased per clinical judgment.
What happens
An increased risk of CNS depression
Interaction Deep Dive
When brimonidine is given together with CNS depressants, the CNS effects of these agents may combine additively1.
Why it happens (mechanism)
Additive CNS depression
How to manage this interaction
Good news: this is usually manageable. The main thing your care team watches for is added drowsiness or dizziness when these two are used together.
- Keep taking both medicines exactly as prescribed unless your doctor or pharmacist tells you otherwise.
- Notice how you feel, especially extra sleepiness, lightheadedness, or slowed breathing.
- Be careful with driving or activities that need full alertness until you know how the combination affects you.
- Your team may adjust your doses to fit you and monitor you more closely if needed.
Bring up any new or worsening drowsiness with your pharmacist or prescriber.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Brimonidine and Buprenorphine together?
Using brimonidine with buprenorphine may add up to more drowsiness or dizziness, so watch for extra sleepiness and check in with your pharmacist or doctor if you notice it. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Brimonidine and Buprenorphine interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Brimonidine and Buprenorphine interaction managed?
Good news: this is usually manageable. The main thing your care team watches for is added drowsiness or dizziness when these two are used together. Keep taking both medicines exactly as prescribed unless your doctor or pharmacist tells you otherwise. Notice how you feel, especially extra sleepiness, lightheadedness, or slowed breathing. Be careful with driving or activities that need full alertnes… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Brimonidine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Product Information: YUVEZZI™ ophthalmic solution, carbachol brimonidine tartrate 2.75%/0.1% ophthalmic solution. Visus Therapeutics Inc. (per FDA), Seattle, WA, 2026. DailyMed
Keep reading about Brimonidine
Keep reading about Buprenorphine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist